Graduate student awarded American Heart Association Fellowship

The heart is the core of life, and for Ph.D. graduate student Katja Birker, it’s the foundation for the beginning of a career.

Scientists identify potential drug candidates for deadly pediatric leukemia

Scientists at Sanford Burnham Prebys have shown that two existing drug candidates—JAK inhibitors and Mepron—hold potential as treatments for a deadly acute myeloid leukemia (AML) subtype that is more common in children.

Conrad Prebys Foundation provides $3 million for pediatric brain cancer research

The Conrad Prebys Foundation provides $3 million to Robert Wechsler-Reya, Ph.D., and his team of researchers to advance a potential drug to treat medulloblastoma—the most common malignant brain tumor in children.